| Current, New and future therapeutic targets in inflammatory bowel disease: a systematic review N Alimohammadi, F Koosha, M Rafeian-Kopaei Current Pharmaceutical Design 26 (22), 2668-2675, 2020 | 13 | 2020 |
| Comparison of the changes in blood glucose level during sedation with midazolam and propofol in implant surgery: a prospective randomized clinical trial N Kaviani, F Koosha, M Shahtusi Journal of Dentistry 15 (3), 135, 2014 | 10 | 2014 |
| The exosomes: staring biomarkers and novel therapeutic strategies F Koosha, N Alimohammadi, M Rafeian-Kopaei Current Pharmaceutical Design 27 (35), 3714-3721, 2021 | 8 | 2021 |
| Lung cancer risk and the inhibitors of angiotensin converting enzyme; an updated review on recent evidence M Khosravian, M Momenzadeh, F Koosha, N Alimohammadi, N Kianpour Immunopathologia Persa 8 (1), e19-e19, 2021 | 6 | 2021 |
| Non-cytotoxic Root Canal Dressing with Improved Antimicrobial Efficacy F Koosha, J Cymerman, T Manders, M Simon, S Walker, M Rafailovich Journal of Endodontics 49 (2), 205-211, 2023 | 3 | 2023 |
| Evaluation of rheological properties and cytotoxicity of bioinks F Koosha, D Silverman, S Taboada, J Li, M Rafailovich MRS Advances 4 (22), 1275-1283, 2019 | 3 | 2019 |
| Ameliorative effects of pirfenidone in chronic kidney disease S Ghodrati, YR Haghi, J Baharani, A Joseph, N Alimohammadi, F Koosha, ... Journal of Nephropharmacology 11 (2), e10458-e10458, 2022 | | 2022 |
| Therapeutic effects of curcumin on kidney disease; an updated review of the current knowledge L Saberian, N Alimohammadi, F Koosha, HV Rahvard, K Ahmadi, ... J Ren Endocrinol 8, e23063, 2022 | | 2022 |
| Engineering a Non-Cytotoxic Root Canal Dressing with Improved Antimicrobial Efficacy F Koosha State University of New York at Stony Brook, 2022 | | 2022 |
| Characterization of a novel antimicrobial agent for endodontic applications A Zhu, J Wolberg, F Koosha, K Etwaru, M Rafailovich Bulletin of the American Physical Society 65, 2020 | | 2020 |
